Physicians Office Resource Volume 11 Issue 5 | Page 3

Clarity to the bone
Introducing GE Healthcare’s DXA Bone Densitometers
with enCORE v17 software’s optional AFF
jiexyvi
#3502
Expand the capabilities of your
DXA systems and your practice
A growing number of patients are risking their bone health by fo rgoing
medication-based treatments for osteoporosis due to concerns about
Atypical Femur Fractures (AFF).
Physicians need a way to enhance confidence in treatment plans
to ensure vital healthy aging for their patients. GE Healthcare’s
DXA Bone Densitometers with enCORE v17 software’s optional
AFF feature provides the ability to quantify focal thickening of the
lateral cortex, to help give patients a clearer picture of their bone
health and assess any potential risks.
See for yourself. Request a free trial offer of GE Healthcare’s
DXA Bone Densitometers with enCORE v17 software’s
optional AFF jiexyvi
and see what’s been missing.
QO
Riepxlgeviw
NbK
Lsri
Nirwmxsqixivw

{mxl
enCORE v17 software’s optional
AFF feature quantifies focal thickening
of the lateral cortex.
gehealthcare.com/encore17
©2017 General Electric Company – All rights reserved.
3